These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9800719)

  • 1. Evaluation of generic drugs in Spain.
    García Alonso F
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():3. PubMed ID: 9800719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Special generic drugs in Spain].
    Carné X; Díez Rodrigálvarez M; García-Alonso F
    Med Clin (Barc); 1999 Mar; 112(9):337-9. PubMed ID: 10220766
    [No Abstract]   [Full Text] [Related]  

  • 3. [Generic drug lines: all is not gold that glitters].
    Córdoba García R
    Aten Primaria; 1999 Oct; 24(7):387-9. PubMed ID: 10592545
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosimilar therapeutic agents: issues with bioequivalence and immunogenicity.
    Schellekens H
    Eur J Clin Invest; 2004 Dec; 34(12):797-9. PubMed ID: 15606720
    [No Abstract]   [Full Text] [Related]  

  • 5. The end of the beginning?
    Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
    [No Abstract]   [Full Text] [Related]  

  • 6. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 7. A vision of the pharmaceutical industry.
    Muñio S
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():5-9. PubMed ID: 9800720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

  • 9. Generic drugs. Save money--but is there a cost?
    Roberts SS
    Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605
    [No Abstract]   [Full Text] [Related]  

  • 10. Impurities in generic pharmaceutical development.
    Kovaleski J; Kraut B; Mattiuz A; Giangiulio M; Brobst G; Cagno W; Kulkarni P; Rauch T
    Adv Drug Deliv Rev; 2007 Jan; 59(1):56-63. PubMed ID: 17196702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are generic and brand name drugs different in terms of quality?
    Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
    [No Abstract]   [Full Text] [Related]  

  • 12. Substituting generic drugs: state roles.
    Cauchi R
    NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
    [No Abstract]   [Full Text] [Related]  

  • 13. EMEA tackles "generic" biologic drug issues.
    Rice M
    J Natl Cancer Inst; 2006 Apr; 98(7):435-6. PubMed ID: 16595776
    [No Abstract]   [Full Text] [Related]  

  • 14. EMEA guidelines on biosimilars and their clinical implications.
    Rossert J
    Kidney Blood Press Res; 2007; 30 Suppl 1():13-7. PubMed ID: 17726338
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals: generic/ therapeutic drug substitution: year end report-2002.
    Floridi T; Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-12. PubMed ID: 12856672
    [No Abstract]   [Full Text] [Related]  

  • 16. Reassurance about bioequivalence of generic thyroxine.
    Feek CM
    N Z Med J; 1992 Jan; 105(926):21. PubMed ID: 1549275
    [No Abstract]   [Full Text] [Related]  

  • 17. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in the pioneer versus generic drug wars.
    Safir PO
    Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002
    [No Abstract]   [Full Text] [Related]  

  • 19. Generic immunosuppressants: the European perspective.
    Christians U
    Transplant Proc; 1999 May; 31(3A Suppl):19S-22S. PubMed ID: 10330954
    [No Abstract]   [Full Text] [Related]  

  • 20. Making medicines safe.
    Videau JY
    Bull World Health Organ; 2001; 79(2):87. PubMed ID: 11242826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.